Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Macau University of Science and Technology has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner, CREWS, JARET JAMES, who is the busiest examiner for the university with 1 pending office action. The prosecution is confined to 1 distinct art unit.
The university's current patent activity is concentrated on a single pending office action. With only 1 distinct examiner and 1 distinct art unit, the prosecution environment is very narrow. CREWS, JARET JAMES is the sole examiner overseeing the university's active biotech patent work.
The concentration of the workload under a single examiner suggests a streamlined prosecution process. Because there is only 1 busiest examiner pending action, the technical focus of the examination remains narrow. Practitioners working with CREWS, JARET JAMES will find that this individual manages the entirety of the university's currently pending work. This structure allows for a very specific legal strategy tailored to the preferences of a single examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CREWS, JARET JAMES | 1 | 43.9% | +71.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18135229 | Method and compounds for inhibiting the MCM complex and their application in cancer treatment | CREWS, JARET JAMES | 70d overdue |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18135229 | Method and compounds for inhibiting the MCM complex and their application in cancer treatment | CREWS, JARET JAMES | 1691 | §103 | Non-Final OA | 70d overdue | Pending | Apr 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMacau University of Science and Technology has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jaret James Crews has the most, with 1 of Macau University of Science and Technology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.